Annovis Bio Inc (ANVS)
13.00
+0.26
(+2.04%)
USD |
NYSE |
Apr 25, 11:27
Annovis Bio Market Cap: 143.15M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 140.28M |
| April 23, 2024 | 130.81M |
| April 22, 2024 | 126.52M |
| April 19, 2024 | 110.77M |
| April 18, 2024 | 108.46M |
| April 17, 2024 | 98.99M |
| April 16, 2024 | 110.99M |
| April 15, 2024 | 122.12M |
| April 12, 2024 | 128.06M |
| April 11, 2024 | 134.34M |
| April 10, 2024 | 129.38M |
| April 09, 2024 | 126.52M |
| April 08, 2024 | 126.19M |
| April 05, 2024 | 122.23M |
| April 04, 2024 | 121.56M |
| April 03, 2024 | 124.32M |
| April 02, 2024 | 123.11M |
| April 01, 2024 | 131.70M |
| March 28, 2024 | 131.03M |
| March 27, 2024 | 132.47M |
| March 26, 2024 | 129.71M |
| March 25, 2024 | 131.03M |
| March 22, 2024 | 124.54M |
| March 21, 2024 | 126.52M |
| March 20, 2024 | 118.71M |
| Date | Value |
|---|---|
| March 19, 2024 | 95.40M |
| March 18, 2024 | 99.35M |
| March 15, 2024 | 96.17M |
| March 14, 2024 | 94.37M |
| March 13, 2024 | 96.17M |
| March 12, 2024 | 98.82M |
| March 11, 2024 | 95.32M |
| March 08, 2024 | 94.90M |
| March 07, 2024 | 93.10M |
| March 06, 2024 | 98.92M |
| March 05, 2024 | 95.85M |
| March 04, 2024 | 96.28M |
| March 01, 2024 | 93.84M |
| February 29, 2024 | 89.61M |
| February 28, 2024 | 93.95M |
| February 27, 2024 | 103.58M |
| February 26, 2024 | 93.84M |
| February 23, 2024 | 105.16M |
| February 22, 2024 | 109.61M |
| February 21, 2024 | 107.70M |
| February 20, 2024 | 106.43M |
| February 16, 2024 | 110.35M |
| February 15, 2024 | 119.34M |
| February 14, 2024 | 109.71M |
| February 13, 2024 | 106.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
17.11M
Minimum
Apr 02 2020
978.76M
Maximum
Jul 13 2021
136.89M
Average
107.60M
Median
Market Cap Benchmarks
| Abbott Laboratories | 185.01B |
| FibroGen Inc | 94.07M |
| Cerus Corp | 295.49M |
| OPKO Health Inc | 836.39M |
| Stereotaxis Inc | 190.13M |
Market Cap Related Metrics
| Price | 13.00 |
| Earnings Yield | -47.85% |